Loading...
•
Sep 30, 2022
Definitive Healthcare Q3 2022 Earnings Report
Reported financial results with revenue exceeding guidance and adjusted EBITDA at the top end of the range.
Key Takeaways
Definitive Healthcare reported a strong Q3 2022 with revenue increasing by 33% year-over-year to $57.4 million. The company's adjusted EBITDA was $16.4 million, representing 29% of revenue, and they experienced key customer wins and product innovations.
Revenue was $57.4 million, a 33% increase from Q3 2021.
Net loss was ($6.4) million, or 11% of revenue.
Adjusted Net Income was $8.9 million, compared to $2.2 million in Q3 2021.
Adjusted EBITDA was $16.4 million, or 29% of revenue.
Forward Guidance
The Company is issuing financial guidance for Q4 2022 and full year 2022.
Positive Outlook
- Revenue is expected to be in the range of $58–59 million, a median 26% increase year over year.
- Adjusted Operating Income is expected to be in the range of $15 – 16 million.
- Adjusted EBITDA is expected to be in the range of $16–17 million.
- Adjusted Net Income is expected to be $6–7 million.
- Adjusted Net Income Per Diluted Share is expected to be $0.03–0.04 on approximately 156.5 million weighted-average shares outstanding.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...